Surgery Partners, Inc.SGRYNASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank77
3Y CAGR+35.7%
5Y CAGR-0.8%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+35.7%/yr
vs -7.1%/yr prior
5Y CAGR
-0.8%/yr
Recent acceleration
Acceleration
+42.8pp
Accelerating
Percentile
P77
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$195.60M-6.7%
2024$209.70M+2.3%
2023$205.00M+162.1%
2022$78.20M+165.1%
2021$29.50M-85.5%
2020$204.00M+264.9%
2019$55.90M-46.7%
2018$104.80M+14.7%
2017$91.34M+6.1%
2016$86.13M-